Pancreatic Cancer Research

ResearcherUniversity of JordanActive in the last 2 years

Hikmat Abdel‐Razeq

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0003-2833-6051; OpenAlex author ID A5032290025. Sources: OpenAlex.

Their work

Papers
3 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
5
Papers, trials and grants by year

2025: 1 paper · 2026: 2 papers

Papers 3

  1. Germline genetic profiling utilizing multigene panel testing in Jordanian patients with pancreatic cancer: a comprehensive cancer center experience. Co-author DOI 10.1186/s12885-026-15669-0↗
  2. Prognostic Impact of Baseline Circulating Tumor DNA (ctDNA) in Pancreatic Ductal Adenocarcinoma: A Systematic Review and Meta-Analysis. Co-author DOI 10.3390/cancers18142286↗
  3. Enhancing Early Detection of Pancreatic Cancer in Genetically Predisposed Individuals: Integrating Advanced Imaging Modalities with Emerging Biomarkers and Liq… Last author DOI 10.2147/btt.s543427↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Asem H. Mansour · 2 shared papers, 2025–2026 · strength 0.51
  2. Rashid H. Abdel-Razeq · 2 shared papers, 2025–2026 · strength 0.47
  3. Abdullah Esmail · 1 shared paper, 2026 · strength 0.29
  4. Maen Abdelrahim · 1 shared paper, 2026 · strength 0.29
  5. Tala Alawabdeh · 1 shared paper, 2026 · strength 0.25

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.